The NICHD conducts and supports a variety of clinical research projects related to pregnancy loss/miscarriage. Select a link below to learn more about these projects.
Featured NICHD Clinical Trials
- Bone Marrow Cell Engraftment of the Uterus
Some hematopoietic stem cell transplant recipients have been found to possess cells in their uterus that come from the donor. The main focus of this clinical trial is to characterize the biological properties of donor stem cells in the reproductive tract of the recipient. The results of this study may reveal therapeutic possibilities using bone marrow–derived cells for gynecologic conditions.
- Maternal Genitourinary Infections and Adverse Perinatal Outcomes
The main focus of this clinical trial is to determine the impact of community-based screening and treatment of abnormal vaginal flora and urinary tract infections during early pregnancy (13 to 19 weeks) on preterm live birth. In addition, this study will determine the prevalence of abnormal vaginal flora and urinary tract infections within the sample population and evaluate the accuracy of simple, low-cost diagnostic tests in a developing country.
- The Safe Passage Study
The main goal of the Safe Passage Study is to improve pregnancy outcomes and infant health. Women from the Northern Plains of the United States and the Western Cape of South Africa will answer questions about health, pregnancy, and life situations several times during their pregnancy and their infants' first year of life in an effort to improve pregnancy outcomes and infant health.
NICHD Clinical Trials
ClinicalTrials.gov Search Results
Information on current NIH-sponsored clinical trials on pregnancy loss, miscarriage, or stillbirth is available by following the link below or by calling 800-411-1222.